Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
00:31:50 EDT Wed 15 Apr 2026
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

Q:PHIO - PHIO PHARMACEUTICALS CORP - https://phiopharma.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
PHIO - Q3.01.17·1.345.01.29+0.054.0240.22677301.22  1.30  1.224.1899  0.812819:21:34Apr 1315 min RT 2¢

Recent Trades - Last 10 of 730
Time ETExPriceChangeVolume
19:21:34Q1.270.03100
19:04:10Q1.270.03500
18:53:30Q1.27070.0307345
18:35:36Q1.270.0335
18:13:46Q1.270.03135
18:09:58Q1.27120.0312150
18:07:51Q1.27180.0318100
18:00:36Q1.270.03115
18:00:36Q1.26990.0299115
17:31:33Q1.29620.05621

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-04-13 07:01U:PHIONews ReleasePhio Pharmaceuticals Announces "Nobel Prize Winning Science Takes on Skin Cancer" in a Fireside Chat with Force Family Office on Wednesday, April 15, 2026
2026-04-09 07:01U:PHIONews ReleasePhio Pharmaceuticals Announces Presentation at Centri Capital Conference on April 14, 2026
2026-03-30 07:01U:PHIONews ReleasePhio Pharmaceuticals Announces Agreement with U.S. cGMP Manufacturing Source for Drug Product, PH-762
2026-03-23 07:01U:PHIONews ReleasePhio Pharmaceuticals Announces American Academy of Dermatology 2026 Presentation Featuring Clinical Study Results from Study of PH-762 for Cutaneous Carcinoma Underscoring Clinical Pipeline Advancement
2026-03-16 11:32U:PHIONews ReleasePhio Pharmaceuticals Announces "A Groundbreaking Approach to Treating Skin Cancer" in a Fireside Chat with Force Family Office
2026-03-10 08:35U:PHIONews ReleasePhio Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12, 2026 11 AM EDT
2026-03-10 07:02U:PHIONews ReleasePhio Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12, 2026, 11 AM EDT
2026-03-05 16:07U:PHIONews ReleasePhio Pharmaceuticals Reports 2025 Year-End Financial Results and Business Update
2026-03-05 07:02U:PHIONews ReleasePhio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
2026-02-19 07:01U:PHIONews ReleasePhio Pharmaceuticals Aligns Leadership Team to Support Next Stage Development of PH-762 and Advancement of PH-894
2026-02-10 07:02U:PHIONews ReleasePhio Announces Safety Monitoring Committee's (SMC) Positive Wrap-up on Lead Clinical Candidate PH-762 in Skin Cancer Trial
2026-01-26 08:16U:PHIONews ReleasePhio Pharmaceuticals Announces Participation in Third Annual DealFlow Discovery Conference
2026-01-20 09:31U:PHIONews ReleasePhio Pharmaceuticals Announces Key Tumor Response Data from all Cohorts in Intratumoral PH-762 Dose Escalation Cutaneous Carcinoma Trial
2026-01-20 07:15U:PHIONews ReleaseSidoti Events, LLC's January Micro-Cap Virtual Conference
2026-01-15 08:46U:PHIONews ReleasePhio Pharmaceuticals Announces Participation in the Sidoti Micro-Cap Virtual Investor Conference January 21-22, 2026
2025-12-23 08:47U:PHIONews ReleasePhio Pharmaceuticals Announces Significant Step Forward in its Drug Development Program for PH-762
2025-11-25 11:31U:PHIONews ReleasePhio Pharmaceuticals Announces Completion of Enrollment in Phase 1b Clinical Trial of INTASYL siRNA Lead Compound PH-762
2025-11-17 08:46U:PHIONews ReleasePhio Pharmaceuticals Announces Upcoming Podium Presentation at the Advanced Therapies USA 2025 Congress
2025-11-13 16:17U:PHIONews ReleasePhio Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update